Pharvaris PHVS
NASDAQ PHVS
$35.25 -0.41 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Change in Account Payables (2020 - 2026)

Pharvaris' (PHVS) quarterly Change in Account Payables came in at -$5.5 million in Q1 2026, down 1462.15% YoY from $406477.4 in Q1 2025, and down 221.57% on a QoQ basis from $4.6 million in Q4 2025.

Analysis

Pharvaris (PHVS) Change in Account Payables (2020 - 2026) Analysis & Trends

Pharvaris (PHVS) has 7 years of Change in Account Payables data on file, last reported at -$5.5 million in Q1 2026.

  • Quarterly Change in Account Payables fell 1462.15% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.2 million (down 272.0% YoY) and the FY2025 annual result came in at -$29272.3, down 101.64% from the prior year.
  • Change in Account Payables eased to -$5.5 million in Q1 2026, from $4.6 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1657.9 billion in Q3 2023 to a low of -$1658.4 billion in Q2 2023.
  • A 5-year average of -$30.2 million and a median of $859138.2 in 2025 frame the typical range for Change in Account Payables.
  • The widest YoY moves for Change in Account Payables: up 56176968.41% in 2023, down 188589424.78% in 2023.
  • Tracing PHVS's Change in Account Payables over 5 years: stood at -$713969.1 in 2022, then slumped by 189.52% to -$2.1 million in 2023, then jumped by 119.05% to $393783.8 in 2024, then jumped by 1056.55% to $4.6 million in 2025, then slumped by 221.57% to -$5.5 million in 2026.
  • The last three Change in Account Payables figures came in at -$5.5 million (Q1 2026), $4.6 million (Q4 2025), and -$5.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10 -1.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.28 Mn
Mar 31, 2026 -5.54 Mn
Dec 31, 2025 4.55 Mn
Sep 30, 2025 -5.10 Mn
Jun 30, 2025 859,138.16
Mar 31, 2025 -354,436.67
Dec 31, 2024 393,783.82
Sep 30, 2024 -64.49 Bn
Jun 30, 2024 63.23 Bn
Mar 31, 2024 2.88 Mn
Dec 31, 2023 -2.07 Mn
Sep 30, 2023 1,657.85 Bn
Jun 30, 2023 -1,658.37 Bn
Mar 31, 2023 1.30 Mn
Dec 31, 2022 -713,969.11
Sep 30, 2022 -1,692.27 Bn
Jun 30, 2022 1,790.93 Bn
Mar 31, 2022 958,803.01
Dec 31, 2021 -1.21 Mn
Sep 30, 2021 419,751.99